Your browser doesn't support javascript.
loading
BCG-activation of leukocytes is sufficient for the generation of donor-independent innate anti-tumor NK and γδ T-cells that can be further expanded in vitro.
Esteso, Gloria; Felgueres, María José; García-Jiménez, Álvaro F; Reyburn-Valés, Christina; Benguría, Alberto; Vázquez, Enrique; Reyburn, Hugh T; Aguiló, Nacho; Martín, Carlos; Puentes, Eugenia; Murillo, Ingrid; Rodríguez, Esteban; Valés-Gómez, Mar.
Afiliação
  • Esteso G; Department of Immunology and Oncology, National Centre for Biotechnology, Spanish National Research Council, Madrid, Spain.
  • Felgueres MJ; Department of Immunology and Oncology, National Centre for Biotechnology, Spanish National Research Council, Madrid, Spain.
  • García-Jiménez ÁF; Department of Immunology and Oncology, National Centre for Biotechnology, Spanish National Research Council, Madrid, Spain.
  • Reyburn-Valés C; Department of Immunology and Oncology, National Centre for Biotechnology, Spanish National Research Council, Madrid, Spain.
  • Benguría A; Servicio de Genómica, Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain.
  • Vázquez E; Servicio de Genómica, Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain.
  • Reyburn HT; Department of Immunology and Oncology, National Centre for Biotechnology, Spanish National Research Council, Madrid, Spain.
  • Aguiló N; Grupo de Genética de Micobacterias, Departamento de Microbiología y Medicina Preventiva, Facultad de Medicina, Universidad de Zaragoza, IIS-Aragon; Zaragoza, Spain and CIBER Enfermedades Respiratorias, Instituto de Salud Carlos III; Madrid, Spain.
  • Martín C; Grupo de Genética de Micobacterias, Departamento de Microbiología y Medicina Preventiva, Facultad de Medicina, Universidad de Zaragoza, IIS-Aragon; Zaragoza, Spain and CIBER Enfermedades Respiratorias, Instituto de Salud Carlos III; Madrid, Spain.
  • Puentes E; Servicio de Microbiología, Hospital Universitario Miguel Servet, IIS Aragon; Zaragoza, Spain.
  • Murillo I; Clinical Research Department y Research & Development Department, Biofabri, Grupo Zendal, O'Porriño, Pontevedra, Spain.
  • Rodríguez E; Clinical Research Department y Research & Development Department, Biofabri, Grupo Zendal, O'Porriño, Pontevedra, Spain.
  • Valés-Gómez M; Clinical Research Department y Research & Development Department, Biofabri, Grupo Zendal, O'Porriño, Pontevedra, Spain.
Oncoimmunology ; 12(1): 2160094, 2023.
Article em En | MEDLINE | ID: mdl-36567803
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Bexiga Urinária / Mycobacterium bovis / Antineoplásicos Limite: Humans Idioma: En Revista: Oncoimmunology Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Espanha
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Bexiga Urinária / Mycobacterium bovis / Antineoplásicos Limite: Humans Idioma: En Revista: Oncoimmunology Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Espanha